Atopic Dermatitis

Brett King, MD, PhD, provides an overview of JAK inhibitors and their interaction with the JAK-STAT pathway.

Non-pharmacological strategies that can help patients with atopic dermatitis cope with symptoms and advice to help healthcare professionals counsel patients on proper use of these products and techniques.

Recommendations on educating primary care physicians about atopic dermatitis and the importance of early referral to dermatologists.

Studies are needed to determine the best treatment regimen for these patients.

The selective topical PDE4 inhibitor demonstrated rapid improvements in IGA and EASI scores and high tolerability in pediatric populations.

On the latest Derm Discussions, Brett King, MD, PhD, joins Brad Glick, DO, to discuss the potential of the JAK inhibitor class for dermatology.

Males and patients with higher disease severity were more likely to attend program sessions.

The FDA will also not meet the PDUFA date for tofacitinib for the treatment of active ankylosing spondylitis.

Upadacitinib has shown promising results for a variety of diseases such as severe atopic dermatitis and psoriatic arthritis, but its future remains uncertain.

The differences in early skin immune changes in pediatric atopic dermatitis (AD) versus long-standing adult AD and variations in the condition’s presentation among patients of color.

Opening a discussion regarding best practices in managing patients with atopic dermatitis, Douglas DiRuggiero, DMSc, PA-C, describes its relationship to eczema and explains at what age it commonly presents in patients.

Less than half of affected patients (42.86%) indicated previous history of conjunctivitis prior to initiating dupilumab treatment.

Despite a global decrease in asthma deaths, researchers say the disease is particularly threatening to patients with atopic dermatitis.

Investigators show that both terms tend to be used in different contexts within the biomedical literature.

Misha Rosenbach, MD, mentions various ways dermatologists (and the population at large) can be more mindful of their impact on the environment

Researchers found that different pets elicit different allergy responses in child participants.

Patients on placebo with a history of systemic non-steroidal immunosuppressants generally fared worse than their treatment-naïve counterparts.

Among 49,197 vaccinated employees at Mass General Brigham, 776 self-reported cutaneous reactions following the first dose.

These results highlight the importance of interventions to address modifiable behaviors and risk factors for these patients.

A personalized topical cream applied for 1 week was shown to reduce Staphylococcus areus colonization and improve clinical outcomes.

Adding platelet-rich plasma to narrowband–ultraviolet B is likely a safe, effective, and efficient means of treating atopic dermatitis.

The COVID-19 pandemic had forced vitiligo patients to delay treatments; however, not much is known about the effects of delaying on disease course.

Misha Rosenbach, MD, gives an overview of climate change and its relevance to dermatology.

Meaningful change thresholds in POEM and DLQI scores have been established for adolescents and adults.

There may be an association between atopic dermatitis severity and diagnosis of ocular disease, such as conjunctivitis.